Clinical Trial Update: S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed disodium for recurrent and unresectable or metastatic chondrosarcoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondrosarcoma

Drugs mentioned

• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Sarcoma | Phase 2 | Status: COMPLETED